title: Parvovirus B19 antibodies in patients with haemophilia A.
authors.forename: K
authors.initials: K
authors.lastname: Peerlinck
authors.forename: P
authors.initials: P
authors.lastname: Goubau
authors.forename: R
authors.initials: R
authors.lastname: Reybrouck
authors.forename: J
authors.initials: J
authors.lastname: Desmyter
authors.forename: J
authors.initials: J
authors.lastname: Vermylen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood*; D001530:Belgium / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D016731:Erythema Infectiosum / Q000097:blood / Q000453:epidemiology* / Q000276:immunology / Q000635:transmission; D005169:Factor VIII / Q000302:isolation & purification / Q000627:therapeutic use; D006467:Hemophilia A / Q000097:blood* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D007124:Immunoenzyme Techniques; D007223:Infant; D008875:Middle Aged; D016732:Parvovirus B19, Human / Q000276:immunology*; D015995:Prevalence; D011933:Reagent Kits, Diagnostic; D012449:Safety
chemical_list: D000914:Antibodies, Viral; D011933:Reagent Kits, Diagnostic; D005169:Factor VIII